Atlas Trials

A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

Clinical trial NCT06908954 · COMPLETED

Trial details

NCT number
NCT06908954
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic ImpairmentHealthy
Start date
2025-03-14
Primary completion
2026-02-06
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.